Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-006699

Options or other derivatives

  • President and CEO acquired 1,550,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-03-10 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +1,250,000 1,250,000 D
2022-03-10 Grant or award : show line 2 in the form Restricted Stock Units +300,000 300,000 D
Loading xslF345X03/ownership.xml…